Overview

PharmacokineticsSafety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A

Status:
RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
This trial is conducted in China. The aim of the trial is to investigate safety,pharmacokinetics and pharmacodynamics of ZSP1273 granules
Phase:
PHASE2
Details
Lead Sponsor:
Guangdong Raynovent Biotech Co., Ltd